In addition, IQGAP3 expression was associated with higher glioma purity, which is a key factor affecting the response to immunotherapy and prognosis of patients, and high tumor purity was associated with poor prognosis of patients [58]. This evidence concerns the gene IQGAP3 and neoplasm.